Try our beta test site
7 studies found for:    t-cell lymphoma [CONDITION] | Open Studies | genetic
Show Display Options
Rank Status Study
1 Recruiting A Blood and Tissue Sample Collection Study of Patients Who Have Inflammatory Bowel Disease, Who Have Been Treated With Adalimumab and Who Developed Hepatosplenic T-Cell Lymphoma
Conditions: Crohn's Disease;   Ulcerative Colitis;   Hepatosplenic T-Cell Lymphoma
Intervention:
2 Not yet recruiting Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen
Conditions: T-cell Acute Lymphoblastic Lymphoma;   T-non-Hodgkin Lymphoma;   T-cell Acute Lymphoblastic Leukemia
Interventions: Genetic: CD5.CAR/28zeta CAR T cells;   Drug: Fludarabine;   Drug: Cytoxan
3 Recruiting Cell-free Circulating DNA in Primary Cutaneous Lymphomas
Conditions: Mycosis Fungoides;   Lymphoma, Large B-cell, Diffuse
Intervention: Genetic: Cytogenetic and molecular studies
4 Recruiting Study of Efficacy and Safety of CTL019 in Adult DLBCL Patients
Condition: Diffuse Large B-cell Lymphoma (DLBCL)
Intervention: Genetic: CTL019
5 Not yet recruiting Multi-Dose CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)
Conditions: Hodgkin's Lymphoma;   Non-Hodgkin Lymphoma
Interventions: Genetic: CAR T Cells;   Drug: Cyclophosphamide;   Drug: Fludarabine
6 Recruiting Tissue Collection for Studies of Lymph Cancer
Conditions: Hodgkin Disease;   Lymphoma, Non-Hodgkin;   Multiple Myeloma;   Lymphomatoid Granulomatosis;   Leukemia-Lymphoma, Adult T-Cell
Intervention:
7 Available Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant
Conditions: Acute Lymphoblastic Leukemia;   Acute Myeloid Leukemia;   Chronic Myeloid Leukemia;   Myelodysplastic Syndrome;   Lymphomas;   Bone Marrow Failure;   Hemoglobinopathy;   Immune Deficiency;   Osteopetrosis;   Cytopenias;   Leukocyte Disorders;   Anemia Due to Intrinsic Red Cell Abnormality
Intervention: Biological: CD34+ enriched, T Cell Depleted donor stem cell product

Study has passed its completion date and status has not been verified in more than two years.